New Moderna Cancer Vaccine Showing Breakthrough Results: ‘A tremendous step forward’
16th December 2022
A new cancer vaccine from Moderna is showing breakthrough results in preventing recurrences of melanoma, and could ward off other types of cancer as well, the Wall Street Journal reported.
In a mid-stage clinical trial involving post-surgery patients, the vaccine was paired with Keytruda, an immunotherapy manufactured by Merck. The risk of relapse or death by skin cancer was lowered by 44% from the use of Keytruda alone.